New learning module for testing the effects of e-cigarette vapor on living cells

New learning module for testing the effects of e-cigarette vapor on living cells

To complement the wide range of information on the potential dangers of vaping, the Cornell University College of Veterinary Medicine has developed a new learning module for high school classrooms that encourages students to directly test the effects of e-cigarette vapor on living cells. "We created this module in direct response to the vaping epidemic spreading among teens and children," said Dr. Donna Cassidy-Hanley, senior research associate and program manager of the Advancing Secondary Science Education Through Tetrahymena (ASSET) program, which developed the module. The program is funded by the National Institutes of Health. On Dec. 5, the Centers for Disease Control and Prevention (CDC) reported 48 deaths and 2,291 hospitalizations in the U.S. due to electronic cigarette use and associated lung injuries. A CDC survey also found that e-cigarettes were the most commonly used tobacco product among high school and middle school students. In 2019, 28% of teens and 11% percent of middle schoolers reported using e-cigarettes in the past 30 days. The kit – which ASSET prepares and sends to teachers at no cost – contains small quantities of e-cigarette vapor condensate, unsmoked vape juice and water that has been vaporized and re-condensed in a clean e-cigarette. Students then apply these materials to a single-celled ciliated protozoan called Tetrahymena, also provided by ASSET, comparing the effect of each additive on cell viability, motility and overall shape. Tetrahymena is a model organism used in research on health and disease-related topics. Substances that affect Tetrahymena's basic cell functions may also interfere with similar human cell functions, such as human cilia that help move harmful inhaled material out of the lungs. "It doesn't look much like a human [cell], but its basic cell processes are very much like those of human cells," said Cassidy-Hanley. The kit also includes an expanded teacher guide that provides basic information about vaping; an introduction to human cilia; additional information on the effects of nicotine on the human body; and a brief summary of studies regarding the effects of e-cigarette vapor on cultured human lung cells. These tools help to facilitate comparison of the students' Tetrahymena results with effects observed in human cells. Human lung cells grown in tissue culture are commonly used to study the effects of e-cigarette vapor on living cells in research labs, but that's obviously not possible in a classroom. This is a useful, instructive alternative that allows students to experimentally explore key biological concepts as well as the damaging effects of vapor. There's a lot of really good educational material available addressing the health issues associated with vaping, especially among children. Our module is unique in that in addition to supplying basic information about vaping, it provides a dramatic and impactful demonstration of the real-life effects of e-cigarette vapor on living cells. Normal, healthy Tetrahymena are constantly in motion, but when the e-cigarette vapor is added, the cells quickly stop swimming and fall to the bottom of the drop, unable to move." Dr. Donna Cassidy-Hanley, senior research associate Related Stories



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More